Barbara Willekens

Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis

2023 | 1. lékařská fakulta, 3. lékařská fakulta

Publikace